ArticleBritish journal of cancer2025
Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer.
Yujin Kato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it